Funder
National Cancer Institute
Publisher
Springer Science and Business Media LLC
Subject
Urology,Gastroenterology,Radiology, Nuclear Medicine and imaging,Radiological and Ultrasound Technology
Reference57 articles.
1. Li R, Shinde A, Fakih M, Sentovich S, Melstrom K, Nelson R, et al. Impact of Surgical Resection on Survival Outcomes After Chemoradiotherapy in Anal Adenocarcinoma. Journal of the National Comprehensive Cancer Network : JNCCN. 2019;17(10):1203-10. doi: https://doi.org/10.6004/jnccn.2019.7309.
2. American Cancer Society. Cancer Facts & Figures 2022 Atlanta: American Cancer Society; 2022.
3. National Cancer Institute Surveillance E, and End Results Program: Cancer Stat Facts: Anal Cancer. https://seer.cancer.gov/statfacts/html/anus.html (2022). Accessed November 10, 2022.
4. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. Lancet (London, England). 1996;348(9034):1049–54.
5. Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1997;15(5):2040-9. doi: https://doi.org/10.1200/jco.1997.15.5.2040.